Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer
Malcolm D. Mason(Royal Marsden Hospital), Padraig Warde(University Health Network), Mahesh Parmar(University College London), Gordana Jovic(MRC Clinical Trials Unit at UCL), Salah El‐Sharkawi(Velindre Cancer Centre), Andrea Hiltz(Velindre Cancer Centre), Luís Souhami(McGill University Health Centre), Bingshu E. Chen(University of Iowa), John Hetherington(Royal Marsden NHS Foundation Trust), Jinka Sathya(Velindre Cancer Centre), P.D.J. Hardman(Velindre Cancer Centre), Edmund Kostashuk(Velindre Cancer Centre), Charles Hayter(Velindre Cancer Centre), John Anderson(Velindre Cancer Centre), Matthew R. Sydes(MRC Clinical Trials Unit at UCL), Mary Gospodarowicz(University Health Network), Wendy R. Parulekar(Unknown), Michael McKenzie(Provincial Health Services Authority), Michael Brundage(Queen's University), Richard Cowan(Peter MacCallum Cancer Centre), Peter Kirkbride(American Society of Clinical Oncology), J. Barber(Velindre Cancer Centre), Gregory P. Swanson(Radiation Oncology Associates)
Cited by 261
Related Papers
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
|Journal of Clinical Oncology|2007|3.9k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
|Journal of Clinical Oncology|2000|2.3k
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
|New England Journal of Medicine|2017|1.8k